Rejuvenation Gateway - Cellular Longevity

MUSE cell research is expanding across multiple areas, but the evidence is not equal for every condition.

Published human studies have explored MUSE cell-based products in areas including subacute ischemic stroke, ALS, cervical traumatic spinal cord injury, neonatal hypoxic-ischemic encephalopathy, acute myocardial infarction, and dystrophic epidermolysis bullosa.

Brain and nervous system
Neurological research includes a randomized placebo-controlled stroke study, as well as smaller early-stage studies examining safety and feasibility in ALS, spinal cord injury, and neonatal brain injury.

Heart
A first-in-human study administered an intravenous MUSE cell-based product to three people following acute myocardial infarction. The study was very small, so larger controlled trials are still required.

Skin
Early Phase I/II research has also investigated intravenous allogeneic MUSE cells in adults with dystrophic epidermolysis bullosa.

Lab and animal research
Preclinical studies continue to examine potential applications in liver fibrosis, kidney injury, muscle damage, inflammation, and other tissue-repair models. These findings help researchers decide which questions may justify future human trials, but they cannot establish clinical effectiveness in people.

This is why the research level matters.

A published human study does not automatically mean a treatment is approved, proven, or appropriate for every patient. Many MUSE studies remain small, early-stage, condition-specific, and focused primarily on safety or feasibility.

Promising science deserves attention, but also careful interpretation. 🌿

Follow our MUSE research series as we separate biological potential, preclinical findings, and human clinical evidence.

DM “MUSE” to learn more about the current research landscape.

WhatsApp +66 81 950 9197 📲

Age Less. Live More.

Feeling better matters, but it is not the whole story.

After a regenerative or longevity program, personal experience is an important part of follow-up.

You may notice changes in:
Energy
How easily you move through the day and recover from activity.

Sleep
Whether rest feels deeper, more consistent, or more restorative.

Pain or discomfort
Changes in intensity, frequency, or how symptoms affect daily life.

Daily function
Your ability to work, exercise, travel, and complete normal activities.

But symptoms can change from day to day.

That is why responsible follow-up should also include measurable information, such as blood tests, vital signs, movement, strength, and clinician assessment.

A single good day does not confirm a lasting outcome, just as one difficult day does not mean that no progress has occurred.

The goal is to compare both your experience and your health data with your original baseline, then observe the direction of change over time.

Regenerative care should not end on treatment day.

Monitoring helps the medical team understand your response, identify concerns early, and decide whether the ongoing plan should remain the same or be adjusted. 🌿

Learn more about personalized stem cell and longevity programs
https://www.rejuvenationgateway.com/

WhatsApp +66 81 950 9197 📲

Age Less. Live More.



Individual experiences do not confirm treatment effectiveness on their own. Follow-up plans, testing, and clinical interpretation should be personalized by a qualified medical professional.

Stem cell suitability is determined by your health profile, not your age alone.

Some people may need additional testing, specialist clearance, an adjusted protocol, or more time before treatment can proceed.

Current infection
A recent fever, active infection, or ongoing antibiotic treatment may require further assessment or postponement. Active infection and clinically significant pre-treatment abnormalities are commonly listed as exclusion criteria in cell-therapy research protocols. citeturn911067search4turn911067search5

Uncontrolled health conditions
Blood pressure, blood sugar, and other medical conditions should be stable enough for the planned procedure. The physician must consider whether any current condition could compromise safety. citeturn911067search4turn911067search5

Complex medications
All prescriptions, supplements, blood thinners, and medicines affecting immune function should be disclosed so the medical team can review possible interactions and procedure-related risks.

Heart, liver, or kidney concerns
Abnormal organ function may require additional laboratory tests or clearance from a relevant specialist before a plan is confirmed.

Extra screening does not automatically mean that treatment is unsuitable.

It allows the medical team to decide whether the plan should be adjusted, delayed, or supported by further evaluation.

This matters because cell-based products may carry risks including infection, inflammatory or immune reactions, and complications related to product processing or administration. citeturn911067search0turn911067search2

Responsible regenerative care begins with careful screening, transparent discussion, and a plan designed around the individual. 🌿

Start with a private medical suitability review.
https://www.rejuvenationgateway.com/

WhatsApp +66 81 950 9197 📲

Age Less. Live More.

Sleep is not passive rest. It is part of the body’s recovery system.

While you sleep, the body continues to regulate essential processes that support healthy aging and long-term resilience.

Immune balance
Consistent sleep helps regulate inflammatory signaling and supports normal immune function.

Tissue repair
Rest gives the body time to maintain tissues, restore energy, and support natural repair processes.

Metabolic health
Healthy sleep patterns are linked to glucose regulation, hormone balance, appetite control, and overall metabolic function.

When sleep is repeatedly disrupted, the body may have less time to complete these recovery processes. Over time, this can affect energy, concentration, inflammation, and the ability to respond to physical stress.

This also matters in regenerative medicine.

Stem cell therapy and other regenerative approaches do not work in isolation. Sleep, nutrition, movement, stress management, and medical follow-up all help shape the biological environment in which recovery takes place.

Longevity is not built only during the hours you are active.

It is also supported during the hours you allow your body to restore itself. 🌙🌿

Learn more about personalized stem cell and longevity programs
https://www.rejuvenationgateway.com/

WhatsApp +66 81 950 9197 📲

Age Less. Live More.



Sleep supports overall health but does not replace medical assessment or treatment. Persistent sleep problems should be evaluated by a qualified healthcare professional.

MUSE cells are being studied in ALS, but this early study was designed to answer a limited question.

ALS, or amyotrophic lateral sclerosis, affects the nerve cells responsible for voluntary movement. As these motor neurons become damaged, muscle weakness and loss of function can progressively develop.

A small Phase II study explored repeated intravenous administration of the investigational MUSE cell product CL2020.

The study included:
5 people living with ALS
This was a very small participant group.

15 million cells per dose
CL2020 was administered through a vein.

One dose each month for six months
Each participant received six monthly doses.

Close clinical monitoring
Researchers observed safety, side effects, and changes in daily function over time.

Why are MUSE cells of interest in neurological research?

They are being studied for characteristics including stress endurance, migration toward injury-related signals, cellular communication, and potential support of damaged tissue environments.

However, this study mainly provides early safety and feasibility information.

With only five participants and no large controlled comparison group, it cannot establish that MUSE cell treatment is effective for ALS.

Larger, controlled clinical studies are still needed to understand possible benefits, appropriate dosing, durability, and which patients may be most suitable. 🌿

Follow our MUSE research series as we separate promising science from proven clinical outcomes.

DM “MUSE” to learn more about the current research landscape.

https://www.rejuvenationgateway.com/

WhatsApp +66 81 950 9197 📲

Age Less. Live More.



CL2020 is an investigational cell product. Early clinical research does not establish effectiveness and should not replace specialist neurological care, approved treatment, or supportive therapy. Availability and suitability vary by country and require individual medical assessment.

Inflammation is not always the enemy.
It is one of the body’s first protective responses to injury, infection, or cellular stress.

During the initial phase, inflammatory signals help:

• Alert the immune system
• Contain potential damage
• Remove harmful material and damaged cells

But recovery also requires a second phase: resolution and repair.

During this phase, the body works to calm inflammatory signals, clear cellular debris, restore balance, and support tissue rebuilding.

The challenge begins when inflammation does not resolve appropriately.

Persistent inflammatory activity may interfere with tissue function, cellular communication, and the body’s natural recovery environment.

This is why regenerative medicine is not simply about “stopping inflammation.”

Research involving mesenchymal stromal cells and other regenerative approaches often explores how biological signaling may help support a more balanced tissue environment and the transition from inflammation toward repair.

The goal is balance, not the complete removal of a response the body needs. 🌿

Learn more about personalized stem cell and longevity programs

https://www.rejuvenationgateway.com/

WhatsApp +66 81 950 9197 📲

Age Less. Live More.




Inflammation and recovery vary according to the underlying condition and individual health profile. Regenerative treatments are not substitutes for medical diagnosis or standard treatment, and suitability requires individual medical assessment.

MUSE cells are being studied in stroke recovery, but what did the clinical research actually test?

One controlled study evaluated the investigational MUSE cell product CL2020 in people recovering from subacute ischemic stroke.

The study included:

35 participants
25 received CL2020 and 10 received placebo.

One intravenous dose
The treatment was administered between 14 and 28 days after the stroke.

52 weeks of follow-up
Researchers monitored safety and clinical outcomes over approximately one year.

Why does the timing matter?

The subacute period begins after the immediate emergency phase, while the brain and surrounding tissues are still undergoing inflammatory, repair, and neurological recovery processes.

MUSE cells are of research interest because they have been studied for characteristics such as:

• Stress endurance
• Migration toward injury-related signals
• Cellular signaling
• Potential tissue-supportive activity

However, this was one study involving one specific patient population and one investigational product.
Its findings should not be interpreted as proof that every stroke patient will benefit, that every MUSE cell product is equivalent, or that MUSE cells replace established stroke treatment and rehabilitation.

Clinical research should always be understood by reviewing the study design, participant group, dose, timing, safety monitoring, and measured outcomes. 🌿

Follow our MUSE research series as we break down the science one study at a time.

DM “MUSE” to learn more about the current research landscape.

https://www.rejuvenationgateway.com/

WhatsApp +66 81 950 9197 📲

Age Less. Live More.


CL2020 remains an investigational cell product. Stem cell therapy is not a substitute for emergency stroke treatment, specialist care, medication, or rehabilitation. Treatment availability and suitability vary by country and require individual medical assessment.

Traveling for regenerative care should not feel complicated.

For international clients, choosing where to receive treatment involves more than the medical program itself.

It is also about knowing that every step of the journey has been thoughtfully coordinated.

At Rejuvenation Gateway, our 4-day regenerative journey in Bangkok is designed to make the experience clear, comfortable, and easy to navigate.

From your initial consultation and personalized treatment planning to accommodation coordination and airport transfer, our team helps arrange the details around your visit.

So instead of managing multiple parts of the trip on your own, you can focus on your health, your recovery, and your time in Bangkok. 🌿

Your journey may include

• Private consultation and medical assessment
• Personalized regenerative treatment planning
• Coordinated hotel stay
• Airport transfer
• Support throughout your visit

For international clients, good care is not only about what happens inside the treatment room.

It is also about how supported you feel from arrival to departure.

Plan your 4-day regenerative journey in Bangkok.

https://www.rejuvenationgateway.com/

WhatsApp +66 81 950 9197 📲

Age Less. Live More.




Treatment suitability, program duration, and travel arrangements may vary according to individual medical assessment and selected program.

One of the most important questions in stem cell research is not only what a cell can become, but how safely it behaves.

MUSE cells have attracted scientific interest because reported preclinical studies have shown a non-tumorigenic profile, with no teratoma formation observed in the research settings studied.

This is particularly relevant when MUSE cells are discussed alongside pluripotent stem cells.

Embryonic stem cells and induced pluripotent stem cells can differentiate into many cell types, but their uncontrolled pluripotency can also create concerns around teratoma formation.

MUSE cells are different.

They are naturally occurring adult cells found within mesenchymal tissues and demonstrate multilineage differentiation potential without the same tumor-forming behavior reported for embryonic pluripotent cells in preclinical research.

Researchers believe several biological characteristics may contribute to this profile, including controlled proliferation and relatively low telomerase activity.

This is one reason MUSE cells continue to attract attention in regenerative medicine research.

At the same time, preclinical evidence does not mean zero risk in every clinical setting.

Cell quality, manufacturing standards, dose, administration route, medical condition, and physician assessment all remain important parts of responsible regenerative care. 🌿

DM “MUSE” to learn more about MUSE cell science and personalized regenerative programs.

https://www.rejuvenationgateway.com/

WhatsApp +66 81 950 9197 📲

Age Less. Live More.



MUSE cell research remains an evolving field. Findings from preclinical studies do not establish the absence of risk in all human applications. Treatment availability, regulatory status, and suitability vary by country and individual medical assessment.

Looking refreshed does not have to mean looking different.

The goal of facial rejuvenation should be to preserve what already feels like you, while supporting skin quality, balance, and a more rested appearance.

Youthlock is a personalized regenerative facial program designed around the individual.

Rather than focusing only on lines or volume, the approach considers the wider skin environment, including tissue quality, cellular communication, recovery, and the natural changes that happen over time.

The result we aim for is not a new face.

It is a version of you that looks refreshed, well-rested, and naturally confident. 🌿

Because rejuvenation should enhance your features, not redefine them.

Explore the Youthlock Facial Program

https://www.rejuvenationgateway.com/

WhatsApp +66 81 950 9197 📲

Age Less. Live More.



Treatment plans and potential outcomes vary between individuals. Medical assessment is required to determine suitability and the appropriate protocol.